The Brighton musculoskeletal Patient-Reported Outcome Measure (BmPROM): An assessment of validity, reliability, and responsiveness.
Elizabeth Bryant, Shemane Murtagh, Laura Finucane and 6 others
PMID 29749667WHAT IT FOUND
The BmPROM is a short, 8-item questionnaire that reliably tracks physical function and wellbeing in musculoskeletal physiotherapy.
It detects significant improvements after treatment and is rated easy to complete by patients, offering a validated tool to measure clinical outcomes across all MSK conditions.
Key findings
01The BmPROM demonstrated good internal consistency and test-retest reliability for its two subscales (Functionality and Wellbeing).
02The measure was responsive to change, with both Functionality and Wellbeing scores showing significant improvement with large effect sizes following physiotherapy treatment.
03The questionnaire was considered user-friendly, with the majority of patients rating it easy to complete and 90% feeling it covered all relevant areas.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The sample size for the test-retest reliability analysis (n=42) was smaller than anticipated due to logistical difficulties. Participants were recruited voluntarily, which may have excluded patients with lower literacy levels, potentially affecting the generalizability of the results to the broader MSK population. External validity was assessed only against the SF-36, a general health measure, without comparison to other specific MSK outcome measures. The study used exploratory factor analysis, which is data-driven rather than theory-driven; confirmatory factor analysis would be needed to fully validate the structural model.
Declared interests
The text does not report any funding sources or conflicts of interest declarations.
The easy way to misread this
Do not assume the BmPROM is superior to existing condition-specific measures or that it captures all aspects of patient experience without further validation. The responsiveness data comes from a small sample (n=25) of patients who completed their treatment, so the effect sizes may not generalize to patients who drop out early or have different clinical trajectories.